Search

everythinglearnresearchcommunity

for

Search:↓

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

Hormonal contraceptives and therapies regulate organ functions and treat various conditions.

Bedaquiline, Telmisartan, Diosmin, Azelastine, and Adapalene may be effective treatments for onchocerciasis.

Potential new drugs for treating PCOS were identified.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

Most patients with PCOS were prescribed medroxyprogesterone acetate or oral contraceptives, with some experiencing side effects or needing prescription changes.

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

Neurosteroids are crucial for stress response, and targeting specific receptors may help treat certain disorders.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

Using existing drugs for new treatments is cost-effective and safer.

The document concludes that H2-antagonists and proton pump inhibitors are highly effective for ulcers, eradicating Helicobacter pylori is important to prevent recurrence, and misoprostol helps with NSAID-related ulcers.

Drug repurposing can speed up and reduce costs in drug discovery, especially for cancer treatment.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

Sphingosine 1-phosphate helps control mechanical pain.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

Skin odorant receptors respond to flavors and could be targeted to improve skin health and treat diseases.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Dyclonine can effectively reduce skin issues by inhibiting the TRPV3 channel.

Activating cannabinoid receptor 1 may help manage psoriasis by reducing certain keratins.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Golvatinib shows promise as a treatment for Omicron in elderly patients.

Kelulut Honey can help regulate sex hormone receptors in rats with Polycystic Ovary Syndrome, similar to common medications.

Daprodustat, combined with PAβN, could be a new antibacterial treatment.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

Steroid hormones are crucial for body functions and have various medical uses, but their misuse can lead to dependence.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

Drug repurposing can create safer, cheaper treatments by finding new uses for existing drugs.